Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-20-137025
Filing Date
2020-05-08
Accepted
2020-05-08 08:36:02
Documents
3
Effectiveness Date
2020-05-08

Document Format Files

Seq Description Document Type Size
1 DEFA14A d926300ddefa14a.htm DEFA14A 30752
2 GRAPHIC g926300g0508052730680.jpg GRAPHIC 3376
3 GRAPHIC g926300g0508052730898.jpg GRAPHIC 3512
  Complete submission text file 0001193125-20-137025.txt   41734
Mailing Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033
Business Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033 908-740-4000
Merck & Co., Inc. (Filer) CIK: 0000310158 (see all company filings)

EIN.: 221918501 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-06571 | Film No.: 20858835
SIC: 2834 Pharmaceutical Preparations